Company Overview

NTD Eurofins – Setting the Standard in Prenatal Screening

For more than 30 years, NTD Eurofins has pioneered the research and development of prenatal screening protocols for open neural tube defects, Down syndrome, Trisomy 18/13 and early onset preeclampsia. NTD Eurofins processes hundreds of thousands of maternal blood specimens each year. Using specially designed analytical workflow cycles and immunoassay systems that ensure accurate testing and documentation, and efficient specimen handling and reporting, NTD provides risk assessment services that help health care professionals and patients make more informed medical decisions. Utilizing our Eurofins national network of laboratories, NTD is also able to offer advanced genetic testing for our customers, providing a full suite of women’s healthcare testing options.

Mission Statement

NTD Labs, an innovative leader in prenatal screening, provides accurate and timely information to healthcare providers and expectant parents. We achieve this through our unwavering dedication to research, exceptional customer service, and continuous improvement.


CA License

Expires: 4/21/2019

CAP Certificate

Expires: 5/19/20


Expires: 6/30/19

FL License

Expires: 3/31/20

MD Permit-Non Expiring

Effective: 7/1/18

PA CLinical Laboratory Permit

Expires: 8/15/19

RI License

Expires: 12/30/18

Click here to meet our clinical leadership team

Learn More